Correlation of Neurodegenerative Biomarkers and Functional Outcome in Patients with Relapsing–Remitting Multiple Sclerosis
Elīna Polunosika(Riga East University Hospital), Guntis Karelis(NeuroRx Research (Canada)), Daina Pastare(Riga East University Hospital), Kaj Blennow(University of Science and Technology of China), Henrik Zetterberg(University of Wisconsin–Madison), Renārs Erts(University of Latvia), Joel Simrén(University of Gothenburg), Monta Feldmane(Riga East University Hospital), Nauris Zdanovskis(Riga East University Hospital)
Cited by 0
Related Papers
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
|Nature Medicine|2019|606
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2022|589
A multicentre validation study of the diagnostic value of plasma neurofilament light
|Nature Communications|2021|554